Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1455673

Cover Image

PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1455673

Rift Valley Fever Vaccines Market, By Product Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

PUBLISHED:
PAGES: 303 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 3250
PDF (5 User License)
USD 4650
PDF (Enterprise User License)
USD 5650

Add to Cart

REPORT HIGHLIGHT

Rift Valley Fever Vaccines Market size was valued at USD 210.45 Million in 2023, expanding at a CAGR of 6.2% from 2024 to 2032.

Rift Valley Fever is a viral illness transmitted through mosquito bites, affecting both humans and animals. The virus spreads through direct contact with infected animal blood and tissues, as well as mosquito bites. While the virus often presents without symptoms, it can lead to serious complications such as encephalitis, blindness, and hemorrhagic fever. Rift Valley Fever vaccines come in two forms: live attenuated RVF vaccine (Smithburn strain) and killed vaccine. Vaccination protects both humans and animals, crucial for food security and economic stability. These vaccines are essential in preventing the spread of this zoonotic disease, playing a significant role in livestock management and public health initiatives, particularly in endemic areas where RVF outbreaks pose substantial risks.

Rift Valley Fever Vaccines Market- Market Dynamics

Increasing awareness through public health education and advancements in social and medical landscapes to propel market demand

The Rift Valley Fever Vaccines Market is experiencing significant growth due to heightened awareness through public health education and advancements in social and medical landscapes. Technological progress enables health and animal professionals to efficiently vaccinate both humans and animals, further driving market expansion. The drivers of Rift Valley Fever vaccines include the increasing prevalence of Rift Valley Fever outbreaks, particularly in endemic regions, which heightens the urgency for effective preventive measures. Additionally, the rising awareness among governments, healthcare organizations, and agricultural sectors about the economic and public health impacts of Rift Valley Fever underscores the importance of vaccination as a proactive approach to disease control. Furthermore, advancements in vaccine technology and research, coupled with collaborative efforts between industry stakeholders and regulatory bodies, contribute to the development and accessibility of Rift Valley Fever vaccines. These drivers collectively emphasize the critical role of vaccination in mitigating the spread of Rift Valley Fever and reducing its associated morbidity and mortality rates. However, concerns regarding potential adverse reactions may impede market growth despite these positive factors.

Rift Valley Fever Vaccines Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.2% over the forecast period (2024-2032)

Based on product type segmentation, Live vaccines was predicted to show maximum market share in the year 2023

Based on Application segmentation, Cattle was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Rift Valley Fever Vaccines Market- Segmentation Analysis:

The Global Rift Valley Fever Vaccines Market is segmented on the basis of Product Type, Application, and Region.

The market is divided into two categories based on product type: Inactivated and Live. Within the Rift Valley Fever vaccine market, live vaccines take precedence in the type segment due to their capacity to elicit robust and enduring immune responses. These vaccines contain weakened or attenuated versions of the Rift Valley Fever virus, mirroring natural infection without inducing illness. This prompts a vigorous immune reaction, generating antibodies and memory cells that confer protection against future infections. Live vaccines are valued for their efficacy and potential to confer broad immunity across various animal species and populations, making them the preferred option for Rift Valley Fever vaccination initiatives.

The market is divided into five categories based on Application: Cattle, Goats, People, Sheep and Other. Regarding application, in 2023, the cattle segment emerges as the dominant sector in the Rift Valley Fever vaccine market. Cattle are highly vulnerable to Rift Valley Fever virus infection, and outbreaks among livestock can carry significant economic repercussions for farmers and the agricultural sector. Vaccinating cattle against Rift Valley Fever helps prevent disease spread, diminish morbidity and mortality rates, and safeguard farmers' livelihoods. Additionally, shielding cattle from Rift Valley Fever is crucial for upholding food security and averting zoonotic transmission to humans, highlighting the significance of vaccination endeavors targeting this pivotal animal demographic.

Rift Valley Fever Vaccines Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Rift Valley Fever Vaccines Market- Competitive Landscape:

In the Rift Valley Fever vaccine market, companies are implementing diverse strategies to advance the development of effective and accessible vaccines. These strategies encompass continuous research aimed at enhancing vaccine formulations, refining dosing regimens, and improving vaccine stability to facilitate easier storage and transportation, particularly in resource-constrained environments. Moreover, companies are engaging in collaborations with governments, international organizations, and research institutions to streamline vaccine development, regulatory approval, and distribution processes. Additionally, educational campaigns are being conducted to raise awareness among farmers, veterinarians, and healthcare workers regarding the importance of vaccination in controlling Rift Valley Fever outbreaks and protecting both animal and human health.

Recent Developments:

In April 2023, a significant development was reported: the initiation of a phase 1 clinical trial assessing the safety of a ChAdOx1 vaccine regarding Rift Valley Fever in UK adults. This non-randomized open-label, trial represents a critical milestone in the journey toward combating Rift Valley Fever and underscores the ongoing efforts to develop effective vaccines against this viral illness.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RIFT VALLEY FEVER VACCINES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Veterinary Serum and Vaccine Research Institute

Medgene Labs

VSVRI

Onderstepoort Biological Products

OBP

Others

GLOBAL RIFT VALLEY FEVER VACCINES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Inactivated
  • Live

GLOBAL RIFT VALLEY FEVER VACCINES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Cattle
  • Goats
  • People
  • Sheep
  • Other

GLOBAL RIFT VALLEY FEVER VACCINES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA
Product Code: ANV2336

Table of Contents

1.Rift Valley Fever Vaccines Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Rift Valley Fever Vaccines Market Snippet by Product Type
    • 2.1.2.Rift Valley Fever Vaccines Market Snippet by Application
    • 2.1.3.Rift Valley Fever Vaccines Market Snippet by Country
    • 2.1.4.Rift Valley Fever Vaccines Market Snippet by Region
  • 2.2.Competitive Insights

3.Rift Valley Fever Vaccines Key Market Trends

  • 3.1.Rift Valley Fever Vaccines Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Rift Valley Fever Vaccines Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Rift Valley Fever Vaccines Market Opportunities
  • 3.4.Rift Valley Fever Vaccines Market Future Trends

4.Rift Valley Fever Vaccines Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Rift Valley Fever Vaccines Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Rift Valley Fever Vaccines Market Landscape

  • 6.1.Rift Valley Fever Vaccines Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Rift Valley Fever Vaccines Market - By Product Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2.Inactivated
    • 7.1.3.Live

8.Rift Valley Fever Vaccines Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Cattle
    • 8.1.3.Goats
    • 8.1.4.People
    • 8.1.5.Sheep
    • 8.1.6.Other

9.Rift Valley Fever Vaccines Market- By Geography

  • 9.1.Introduction
    • 9.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2.North America
    • 9.2.1.Overview
    • 9.2.2.Rift Valley Fever Vaccines Key Manufacturers in North America
    • 9.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.6.U.S.
      • 9.2.6.1.Overview
      • 9.2.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.2.6.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.7.Canada
      • 9.2.7.1.Overview
      • 9.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.2.7.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.Europe
    • 9.3.1.Overview
    • 9.3.2.Rift Valley Fever Vaccines Key Manufacturers in Europe
    • 9.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.6.Germany
      • 9.3.6.1.Overview
      • 9.3.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.6.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.7.Italy
      • 9.3.7.1.Overview
      • 9.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.7.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.8.United Kingdom
      • 9.3.8.1.Overview
      • 9.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.8.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.9.France
      • 9.3.9.1.Overview
      • 9.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.9.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.10.Russia
      • 9.3.10.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.2.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.10.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.11.Netherlands
      • 9.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.11.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.12.Sweden
      • 9.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.12.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.13.Poland
      • 9.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.13.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.14.Rest of Europe
      • 9.3.14.1.Overview
      • 9.3.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.14.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.Asia Pacific (APAC)
    • 9.4.1.Overview
    • 9.4.2.Rift Valley Fever Vaccines Key Manufacturers in Asia Pacific
    • 9.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.6.India
      • 9.4.6.1.Overview
      • 9.4.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.6.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.7.China
      • 9.4.7.1.Overview
      • 9.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.7.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.8.Japan
      • 9.4.8.1.Overview
      • 9.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.8.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.9.South Korea
      • 9.4.9.1.Overview
      • 9.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.9.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.10.Australia
      • 9.4.10.1.Overview
      • 9.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.10.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.11.Thailand
      • 9.4.11.1.Overview
      • 9.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.11.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.12.Indonesia
      • 9.4.12.1.Overview
      • 9.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.12.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.13.Philippines
      • 9.4.13.1.Overview
      • 9.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.13.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.14.Rest of APAC
      • 9.4.14.1.Overview
      • 9.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.14.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5.Latin America
    • 9.5.1.Overview
    • 9.5.2.Rift Valley Fever Vaccines Key Manufacturers in Latin America
    • 9.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.6.Brazil
      • 9.5.6.1.Overview
      • 9.5.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.6.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.7.Mexico
      • 9.5.7.1.Overview
      • 9.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.7.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.8.Argentina
      • 9.5.8.1.Overview
      • 9.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.8.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.9.Colombia
      • 9.5.9.1.Overview
      • 9.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.9.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.10.Rest of LATAM
      • 9.5.10.1.Overview
      • 9.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.10.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.Middle East and Africa
    • 9.6.1.Overview
    • 9.6.2.Rift Valley Fever Vaccines Key Manufacturers in Middle East and Africa
    • 9.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.6.Saudi Arabia
      • 9.6.6.1.Overview
      • 9.6.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.6.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.7.United Arab Emirates
      • 9.6.7.1.Overview
      • 9.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.7.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.8.Israel
      • 9.6.8.1.Overview
      • 9.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.8.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.9.Turkey
      • 9.6.9.1.Overview
      • 9.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.9.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.10.Algeria
      • 9.6.10.1.Overview
      • 9.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.10.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.11.Egypt
      • 9.6.11.1.Overview
      • 9.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.11.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.12.Rest of MEA
      • 9.6.12.1.Overview
      • 9.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.12.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

10.Key Vendor Analysis- Rift Valley Fever Vaccines Industry

  • 10.1.Competitive Dashboard
  • 10.2.Company Profiles
    • 10.2.1.Veterinary Serum and Vaccine Research Institute
    • 10.2.2.Medgene Labs
    • 10.2.3.VSVRI
    • 10.2.4.Onderstepoort Biological Products
    • 10.2.5.OBP
    • 10.2.6.Others

11.360 Degree Analyst View

12.Appendix

  • 12.1.Research Methodology
  • 12.2.References
  • 12.3.Abbreviations
  • 12.4.Disclaimer
  • 12.5.Contact Us
Product Code: ANV2336

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Rift Valley Fever Vaccines Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Rift Valley Fever Vaccines Market, by Product Type 2019-2032 (USD Million)
  • TABLE Rift Valley Fever Vaccines Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Rift Valley Fever Vaccines Market, by Application 2019-2032 (USD Million)
  • TABLE Rift Valley Fever Vaccines Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Rift Valley Fever Vaccines Market, by Region 2019-2032 (USD Million)
  • TABLE North America Rift Valley Fever Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Rift Valley Fever Vaccines Market, by Product Type, 2019-2032 (USD Million)
  • TABLE North America Rift Valley Fever Vaccines Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Rift Valley Fever Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Rift Valley Fever Vaccines Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe Rift Valley Fever Vaccines Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Rift Valley Fever Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Rift Valley Fever Vaccines Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Rift Valley Fever Vaccines Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Rift Valley Fever Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Rift Valley Fever Vaccines Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America Rift Valley Fever Vaccines Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Rift Valley Fever Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Rift Valley Fever Vaccines Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Rift Valley Fever Vaccines Market, by Application, 2019-2032 (USD Million)

List of Figures

  • FIGURE Rift Valley Fever Vaccines Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Product Type segment market share analysis, 2023 & 2032
  • FIGURE Product Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Rift Valley Fever Vaccines Market share and leading players, 2023
  • FIGURE Europe Rift Valley Fever Vaccines Market share and leading players, 2023
  • FIGURE Asia Pacific Rift Valley Fever Vaccines Market share and leading players, 2023
  • FIGURE Latin America Rift Valley Fever Vaccines Market share and leading players, 2023
  • FIGURE Middle East and Africa Rift Valley Fever Vaccines Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Rift Valley Fever Vaccines Market share analysis by country, 2023
  • FIGURE Germany Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Rift Valley Fever Vaccines Market share analysis by country, 2023
  • FIGURE India Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Phillipines Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Rift Valley Fever Vaccines Market share analysis by country, 2023
  • FIGURE Brazil Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Rift Valley Fever Vaccines Market share analysis by country, 2023
  • FIGURE Saudi Arabia Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!